Target intelligence / Profile preview

Purinergic Receptor P2X Family (P2XRs)

Target
P2XRs
Molecular classification
Ligand-gated ion channel, Receptor
01

Overview

The purinergic receptor P2X family comprises a group of ligand-gated ion channels that are activated by extracellular adenosine 5'-triphosphate (ATP). Each functional receptor is a trimeric complex formed by homo- or heterotrimerization of seven known mammalian subunits (P2X1-P2X7). Upon activation by ATP, these channels allow rapid influx of Na⁺ and Ca²⁺ ions and efflux of K⁺ ions across the cell membrane, leading to depolarization and initiating various downstream signaling events. P2X receptors play critical roles in numerous physiological processes, including modulation of cardiac rhythm and contractility, regulation of vascular tone, mediation of nociception, contraction in smooth muscle tissues, platelet aggregation, activation of immune cells, induction of apoptosis, and neuronal-glial communication. Dysregulation or altered expression/functionality has been implicated in chronic pain syndromes, inflammatory diseases, thrombosis, neurological disorders, cardiovascular diseases, and cancer progression. Selective agonists/antagonists for specific subtypes have therapeutic potential for treating these conditions.

Other names
P2X receptorsP2XR
02

Mechanism of action

Binding of ATP induces conformational changes that open the central cation channel pore, allowing rapid influx of Na⁺ and Ca²⁺ ions and efflux of K⁺ ions, leading to depolarization and downstream signaling events.

03

Biological functions

Fast synaptic transmissionInflammationPain perceptionMuscle contractionModulation of cardiac rhythm and contractilityRegulation of vascular tonePlatelet aggregationImmune cell activationNeuronal-glial communicationApoptosis
04

Disease associations

Chronic pain syndromesInflammatory diseasesThrombosisNeurological disordersCardiovascular diseasesCancer progression
05

Safety considerations

Dysregulation or altered expression/functionality can lead to various diseases.Selectivity profiles for individual receptor isoforms need to be improved for clinical applications.
06

Interacting drugs

Selective agonists for specific subtypes

1 more in the full profile.

Beyond the preview

Go deeper on Purinergic Receptor P2X Family (P2XRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Purinergic Receptor P2X Family (P2XRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call